<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药事纵横 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-18T01:31:06+08:00</updated>
  <subtitle>药事纵横是一个由多位制药精英联合创办的媒体平台，旨在分享与传递药品研发、生产和注册中所涉及的技术、经验和情报，欢迎关注和投稿！投稿请发442015666@qq.com</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>GLP-1受体激动剂：能否成为未来降糖药的中流砥柱？</title>
    <updated>2020-12-17T23:04:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/jk5GnwrfPm4VI1MQC_b8vw</id>
    <link href="https://mp.weixin.qq.com/s/jk5GnwrfPm4VI1MQC_b8vw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>精彩回顾 | 2020药物制剂前沿技术高峰论坛圆满落幕！</title>
    <updated>2020-12-17T23:04:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/sRUiHfx-31GJ70QV0ACS1A</id>
    <link href="https://mp.weixin.qq.com/s/sRUiHfx-31GJ70QV0ACS1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>气相色谱毛细管柱选择理论</title>
    <updated>2020-12-17T23:04:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/kD2n_34ItSI4NBD_EK1L7A</id>
    <link href="https://mp.weixin.qq.com/s/kD2n_34ItSI4NBD_EK1L7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新药临床前和初期临床研究阶段的制剂研究策略</title>
    <updated>2020-12-17T23:04:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/qZBLxF4LHyh-eJ5XSpA5dA</id>
    <link href="https://mp.weixin.qq.com/s/qZBLxF4LHyh-eJ5XSpA5dA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>低剂量口服固体制剂——处方开发的几点考虑</title>
    <updated>2020-12-16T22:51:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/azZdR8JrnU62JAALPkRKYQ</id>
    <link href="https://mp.weixin.qq.com/s/azZdR8JrnU62JAALPkRKYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年终巨献，不负众望！CPhI &amp; P-MEC China盛大启幕！</title>
    <updated>2020-12-16T22:51:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/NEn7NrtH9ZXmBwA3u26Mww</id>
    <link href="https://mp.weixin.qq.com/s/NEn7NrtH9ZXmBwA3u26Mww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准今年第48个新药：用于光化性角化病治疗</title>
    <updated>2020-12-16T22:51:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/TaF8z6MS3w9g5-hmQLbN2g</id>
    <link href="https://mp.weixin.qq.com/s/TaF8z6MS3w9g5-hmQLbN2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从药物体内吸收过程认识制剂开发</title>
    <updated>2020-12-16T22:51:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/3qjZrJMhh0-Y_k1zjhpVCQ</id>
    <link href="https://mp.weixin.qq.com/s/3qjZrJMhh0-Y_k1zjhpVCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>谈谈创新药的质量标准研究</title>
    <updated>2020-12-15T20:06:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/-7QLbyBZ-wWUJEgak6Uhzg</id>
    <link href="https://mp.weixin.qq.com/s/-7QLbyBZ-wWUJEgak6Uhzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药品上市后变更技术研究、申报策略及M4申报资料撰写专题培训</title>
    <updated>2020-12-15T20:06:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/hkcGeG863QhAK4dLFYufcQ</id>
    <link href="https://mp.weixin.qq.com/s/hkcGeG863QhAK4dLFYufcQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准首个PET成像剂，用于PSMA阳性的前列腺癌诊断</title>
    <updated>2020-12-15T20:06:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/GhPvjF16phh5uQNloTFhBw</id>
    <link href="https://mp.weixin.qq.com/s/GhPvjF16phh5uQNloTFhBw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>扎心版2020年医药关键词，你经历了几个？</title>
    <updated>2020-12-15T20:06:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/6TRUGmEeA_jSs05AtYz1Jg</id>
    <link href="https://mp.weixin.qq.com/s/6TRUGmEeA_jSs05AtYz1Jg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>被忽略的 “XRD标准谱”的获取技巧</title>
    <updated>2020-12-14T21:46:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/3hBbpq1479IIl5O8BAvg6g</id>
    <link href="https://mp.weixin.qq.com/s/3hBbpq1479IIl5O8BAvg6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>我在CPhI2020鹰谷电子实验记录本展台，恭候您驾临</title>
    <updated>2020-12-14T21:46:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/9IxELOm62p847QiGTPERyw</id>
    <link href="https://mp.weixin.qq.com/s/9IxELOm62p847QiGTPERyw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家局批准了恒瑞的fluzoparib用于卵巢癌治疗</title>
    <updated>2020-12-14T21:46:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/8xDCDCq6JU4QXq9T4PF5og</id>
    <link href="https://mp.weixin.qq.com/s/8xDCDCq6JU4QXq9T4PF5og" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判今日开启！两次报价，超预期价15%出局</title>
    <updated>2020-12-14T21:46:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/HAdV6Qz-87BSjoBkHHNAVw</id>
    <link href="https://mp.weixin.qq.com/s/HAdV6Qz-87BSjoBkHHNAVw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基于溶剂的ASD（无定型固体分散体）设计思路</title>
    <updated>2020-12-13T20:00:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/GxtZPsa36pPdvCCZ0yDqgA</id>
    <link href="https://mp.weixin.qq.com/s/GxtZPsa36pPdvCCZ0yDqgA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>巅峰论道|走进CPhI大咖局 开启制药行业思想盛宴</title>
    <updated>2020-12-13T20:00:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/7_Y5E7occCSeHDIhBwukvQ</id>
    <link href="https://mp.weixin.qq.com/s/7_Y5E7occCSeHDIhBwukvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准口服小分子用于遗传性血管性水肿预防</title>
    <updated>2020-12-13T20:00:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/WbzsptX1YpQH5V5JoE9R2w</id>
    <link href="https://mp.weixin.qq.com/s/WbzsptX1YpQH5V5JoE9R2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>以毒攻毒| 聊聊火热的溶瘤病毒抗癌疗法</title>
    <updated>2020-12-13T20:00:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/J9KrzrvsdhjBRZNGwe1gBg</id>
    <link href="https://mp.weixin.qq.com/s/J9KrzrvsdhjBRZNGwe1gBg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>